Your monthly Zejula cost savings if eligible
With our assistance, you could access the Zejula patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Zejula patient assistance?
We review each Zejula enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Zejula patient assistance program?
Our process makes it as easy as possible to apply for the Zejula patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Zejula, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx a Zejula coupons provider?
NiceRx is not a Zejula coupon, Zejula discount card, or Zejula copay card provider. We do not offer Zejula manufacturer coupons, Zejula discounts, rebates, Zejula savings cards, trial offers, or free Zejula samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Zejula
- Your insurance company will not pay for your Zejula prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Zejula cost without insurance?
Without insurance, Zejula costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Zejula 100 mg capsules will cost around $8,000 for 30 capsules.
How much does Zejula cost with insurance?
The copay for Zejula will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Zejula?
Zejula is an FDA (U.S. Food and Drug Administration) approved medication manufactured by GlaxoSmithKline (GSK).
It is a poly(ADP-ribose) polymerase PARP inhibitor used for:
- The maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in complete or partial response to first-line platinum-based chemotherapy
- The maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy
- To treat adult patients with advanced ovarian cancer, fallopian tube, or primary peritoneal cancer who have already been treated with three or more chemotherapy regimens and whose cancer is connected to homologous recombination deficiency (HRD) positive status, defined by either – a deleterious or suspected deleterious BRCA mutation, or genomic instability and who have progressed more than six months after responding to the last platinum-based chemotherapy
What doses of Zejula are available?
Zejula is available in capsule form, in the following doses: 100 mg.
The starting dose for recurrent ovarian cancer is 300 mg once daily.
The usual adult dose for fallopian tube cancer, ovarian cancer, or peritoneal cancer is 300 mg orally once a day until disease progression or unacceptable levels of toxicity occur.
Treatment should be started no later than 8 weeks after a patient’s most recent platinum-containing regimen.
Zejula is usually taken once a day, at the same time each day, with or without food, until your body no longer responds to it. The capsule should be swallowed whole. Not crushed, chewed, broken, or opened. It may be taken at bedtime if it upsets your stomach.
Zejula should be taken exactly as it was prescribed. Follow all directions on your prescription label and read all prescribing information or instruction sheets. Always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Zejula active ingredients
Niraparib is the only once-daily PARP inhibitor in first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer.
Niraparib is an inhibitor of PARP enzymes, including PARP-1 and PARP-2, that play a role in DNA repair. Studies have shown that niraparib-induced cytotoxicity involves inhibition of PARP enzymatic activity and increased production of PARP-DNA complexes. This results in DNA damage, apoptosis, and cell death. Increased niraparib-induced cytotoxicity was seen in tumor cell lines with or without BRCA½.
Zejula side effects
The most common side effects caused by Zejula in clinical trials include:
- Indigestion, stomach pain, loss of appetite, nausea, vomiting
- Constipation, diarrhea
- Palpitations, irregular heartbeats, feeling short of breath
- Abnormal liver function or other blood tests
- Hypertension (high blood pressure)
- Little or no urination, changes in the color of your urine, painful urination
- Dry mouth, mouth sores
- Back pain, muscle or joint pain
- Headache, dizziness, anxiety
- Problems sleeping (insomnia)
- Cough, sore throat
In rare instances, Zejula can cause more serious side effects. These can include:
- Signs of a bone marrow disorder – fever, frequent infections, tiredness, feeling short of breath, weight loss, blood in your urine or stools, easy bruising or bleeding
- Irregular heartbeats
- Sores or white patches in or around your mouth, problems swallowing or talking, dry mouth, altered sense of taste
- Urinary tract infections – pain or burning when you urinate
- Severe headaches, blurred vision
- Thrombocytopenia (low blood platelet counts)
- Anemia (low red blood cell counts)
- Neutropenia (low levels of neutrophils, a type of white blood cell)
- Hematological toxicity or myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) – weakness, feeling tired, fever, weight loss, frequent infections, bruising, bleeding easily, breathlessness, blood in urine or stool
Your doctor will assess the benefits of using Zejula against your risk of side effects. Get emergency medical help if you have signs of an allergic reaction to Zejula: hives, difficulty breathing, swelling of your face, lips, tongue, or throat.
Patients are encouraged to report negative side effects or adverse reactions of Zejula to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Zejula drug interactions
No clinical drug interaction studies have been performed with Zejula. You are advised to speak to a healthcare professional before initiating treatment with Zejula.
You should not use Zejula if you:
- Are allergic to the active ingredient niraparib
- Are allergic to any of the other ingredients in Zejula
- Are anyone younger than 18 years old
- Are pregnant or planning to become pregnant – Zejula could harm the unborn baby or cause a miscarriage. Use birth control to prevent pregnancy while you are using this medicine and for at least 6 months after your last dose. You may need to have a negative pregnancy test before commencing treatment
- Are breastfeeding or are planning to breastfeed – Do not breastfeed while using this medicine and for at least 1 month after your last dose
Talk to your doctor before using Zejula if you:
- Are taking any of the medications that could interact with Zejula
- Have heart disease
- Have high blood pressure
- Have liver or kidney disease
Zejula is the trademark brand name for niraparib manufactured by GlaxoSmithKline (GSK). A generic version of niraparib is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Zejula savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.